A former postdoc at Emory and Georgetown Universities falsified data in manuscripts and a grant application to the U.S. National Institutes of Health, according to the Office of Research Integrity (ORI) at the U.S. Department of Health and Human Services.
Mahandranauth Chetram committed misconduct while at Georgetown, the ORI said in a finding released today Continue reading Former Emory, Georgetown postdoc falsified cancer research data: ORI
The week at Retraction Watch featured the temporary removal of the director of the U.S. HHS’ Office of Research Integrity, a mass resignation of an journal’s editorial board, and a court injunction against OMICS. Here’s what was happening elsewhere: Continue reading Weekend reads: Clinical trials in hotel rooms; dressing as a pirate; reducing replication-related stress
The week at Retraction Watch featured a the story of how a nonexistent paper earned 400 ciations, a lawsuit filed against a journal for publishing criticism, and the retraction and replacement of a paper by a group of anti-vaccine advocates. Here’s what was happening elsewhere: Continue reading Weekend reads: Ethical issues could cost university millions in funding; Stolen bone raises questions; Ingelfinger rides again
The week at Retraction Watch featured mass resignations from a journal’s editorial board, software that writes papers for you, and a retracted retraction. Here’s what was happening elsewhere: Continue reading Weekend reads: Publishing’s day of reckoning; an Impact Factor discount — on lunch; a prize for negative results
The week at Retraction Watch featured a revoked PhD, more news about Paolo Macchiarini, and a head-scratcher about a retraction involving astronauts. Here’s what was happening elsewhere:
The week at Retraction Watch featured a retraction by a Nobel laureate, the eight excuses journal editors hear in responses to questions about data, and a description of a “disease” that affects many scientists. Here’s what was happening elsewhere: Continue reading Weekend reads: No peer review crisis?; Fake conferences overwhelm real ones; Bullying vs. criticism
The week at Retraction Watch featured a journal that will pay authors royalties, a new estimate of how many papers are affected by contaminated cell lines, and threats by more than 20 researchers at Johns Hopkins to resign from a journal’s editorial board if a paper isn’t retracted. Here’s what was happening elsewhere: Continue reading Weekend reads: A proposal to end NSF watchdog; Power pose criticism redux; A limit to lifetime word count?
The week at Retraction Watch featured the retraction of a paper that had been called “anti-vaccine pseudoscience,” a retraction following threats of violence against an editor, and an editorial board member’s resignation over how a journal handled a case of plagiarism. Here’s what was happening elsewhere: Continue reading Weekend reads: Systemic fraud in China; science without journals; authorship rules decay
The week at Retraction Watch featured admissions of fake data from a biotech company whose compound is now in clinical trials, a look at who recycles text, and the apparent demotion of a researcher who had a paper on video games retracted. Here’s what was happening elsewhere: Continue reading Weekend reads: Why critics criticize; a Big Bang Theory retraction; Nobels under scrutiny
The week at Retraction Watch featured a look at retractions in China, and an expression of concern for a paper co-authored by a controversial journalist in Australia. Here’s what was happening elsewhere: Continue reading Weekend reads: Preprints under scrutiny; a math retraction in politics; proving yourself wrong